231 related articles for article (PubMed ID: 20022942)
1. An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.
Buddai SK; Layzer JM; Lu G; Rusconi CP; Sullenger BA; Monroe DM; Krishnaswamy S
J Biol Chem; 2010 Feb; 285(8):5212-23. PubMed ID: 20022942
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
[TBL] [Abstract][Full Text] [Related]
3. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
4. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
Stevic I; Berry LR; Chan AK
J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
8. Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.
Boskovic DS; Krishnaswamy S
J Biol Chem; 2000 Dec; 275(49):38561-70. PubMed ID: 10984491
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor V: a plethora of anticoagulant molecules.
Kalafatis M
Curr Opin Hematol; 2005 Mar; 12(2):141-8. PubMed ID: 15725905
[TBL] [Abstract][Full Text] [Related]
10. Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex.
Betz A; Krishnaswamy S
J Biol Chem; 1998 Apr; 273(17):10709-18. PubMed ID: 9553135
[TBL] [Abstract][Full Text] [Related]
11. Modulation of prothrombinase assembly and activity by phosphatidylethanolamine.
Majumder R; Liang X; Quinn-Allen MA; Kane WH; Lentz BR
J Biol Chem; 2011 Oct; 286(41):35535-35542. PubMed ID: 21859710
[TBL] [Abstract][Full Text] [Related]
12. Active site-independent recognition of substrates and product by bovine prothrombinase: a fluorescence resonance energy transfer study.
Boskovic DS; Troxler T; Krishnaswamy S
J Biol Chem; 2004 May; 279(20):20786-93. PubMed ID: 14988397
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
14. HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase.
Kretz CA; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2006 Dec; 281(49):37477-85. PubMed ID: 17046833
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex.
Stevic I; Chan HH; Berry LR; Chander A; Chan AK
J Biochem; 2013 Jan; 153(1):103-10. PubMed ID: 23100269
[TBL] [Abstract][Full Text] [Related]
17. Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples.
Soule EE; Yu H; Olson L; Naqvi I; Kumar S; Krishnaswamy S; Sullenger BA
Cell Chem Biol; 2022 Feb; 29(2):215-225.e5. PubMed ID: 35114109
[TBL] [Abstract][Full Text] [Related]
18. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
19. Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex.
Qureshi SH; Yang L; Manithody C; Rezaie AR
Biochemistry; 2009 Jun; 48(22):5034-41. PubMed ID: 19378973
[TBL] [Abstract][Full Text] [Related]
20. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
Tracy PB; Eide LL; Mann KG
J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
